Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension

CONTEXT: Identification of patients with endocrine forms of hypertension (EHT) (primary hyperaldosteronism [PA], pheochromocytoma/paraganglioma [PPGL], and Cushing syndrome [CS]) provides the basis to implement individualized therapeutic strategies. Targeted metabolomics (TM) have revealed promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Erlic, Zoran, Reel, Parminder, Reel, Smarti, Amar, Laurence, Pecori, Alessio, Larsen, Casper K, Tetti, Martina, Pamporaki, Christina, Prehn, Cornelia, Adamski, Jerzy, Prejbisz, Aleksander, Ceccato, Filippo, Scaroni, Carla, Kroiss, Matthias, Dennedy, Michael C, Deinum, Jaap, Langton, Katharina, Mulatero, Paolo, Reincke, Martin, Lenzini, Livia, Gimenez-Roqueplo, Anne-Paule, Assié, Guillaume, Blanchard, Anne, Zennaro, Maria Christina, Jefferson, Emily, Beuschlein, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993566/
https://www.ncbi.nlm.nih.gov/pubmed/33382876
http://dx.doi.org/10.1210/clinem/dgaa954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993566/
https://www.ncbi.nlm.nih.gov/pubmed/33382876
http://dx.doi.org/10.1210/clinem/dgaa954

Ejemplares similares